The price of BioAge Labs Inc (NASDAQ:BIOA) shares last traded on Wall Street rose 2.36% to $6.08.
BIOA stock price is now -64.94% away from the 50-day moving average and -66.42% away from the 200-day moving average. The market capitalization of the company currently stands at $218.27M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $40 to $5, Morgan Stanley Downgraded its rating from Overweight to Underweight for BioAge Labs Inc (NASDAQ: BIOA). On December 09, 2024, Jefferies Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $42 to quote $7, while ‘Citigroup’ rates the stock as ‘Neutral’
In other news, Pande Vijay Satyanand, Director bought 126,793 shares of the company’s stock on Oct 01 ’24. The stock was bought for $2,501,626 at an average price of $19.73. Upon completion of the transaction, the Director now directly owns 1,026,793 shares in the company, valued at $6.24 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 02 ’24, Director Pande Vijay Satyanand bought 67,096 shares of the business’s stock. A total of $1,323,804 was incurred on buying the stock at an average price of $19.73. This leaves the insider owning 1,093,889 shares of the company worth $6.65 million. A total of 42.93% of the company’s stock is owned by insiders.
During the past 12 months, BioAge Labs Inc has had a low of $3.85 and a high of $26.62. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 17.63, and a quick ratio of 17.63. The fifty day moving average price for BIOA is $17.7022 and a two-hundred day moving average price translates $18.302097 for the stock.
The latest earnings results from BioAge Labs Inc (NASDAQ: BIOA) was released for 2024-09-30.
